We are live on ! Find out more
SCLN

Sciclone Pharmaceuticals Inc
SCLN

Delisted

SCLN was delisted on the 13th of October, 2017.

Back to rankings

104 hedge funds and large institutions have $147M invested in Sciclone Pharmaceuticals Inc in 2013 Q2 according to their latest regulatory filings, with 104 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

12% less call options, than puts

Call options by funds: $707K | Put options by funds: $806K

Holders
104
Holders Change
+104
Holders Change %
–
% of All Funds
3.39%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
104
Increased
–
Reduced
–
Closed
–
Calls
$707K
Puts
$806K
Net Calls
-$99K
Net Calls Change
-$99K

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Franklin Resources
1
Franklin Resources
California
$18.4M +$17.7M +3,718,160 New
BIT
2
BlackRock Institutional Trust
California
$14.2M +$13.6M +2,865,111 New
LSV Asset Management
3
LSV Asset Management
Illinois
$14.1M +$13.5M +2,838,665 New
Dimensional Fund Advisors
4
Dimensional Fund Advisors
Texas
$10.2M +$9.82M +2,064,053 New
Schroder Investment Management Group
5
Schroder Investment Management Group
United Kingdom
$10.2M +$9.74M +2,046,396 New
BFA
6
BlackRock Fund Advisors
California
$9.24M +$8.86M +1,862,167 New
Vanguard Group
7
Vanguard Group
Pennsylvania
$6.64M +$6.37M +1,339,519 New
State Street
8
State Street
Massachusetts
$5.14M +$4.93M +1,036,138 New
NCM
9
Nantahala Capital Management
Connecticut
$4.6M +$4.42M +928,209 New
Northern Trust
10
Northern Trust
Illinois
$4.17M +$4M +840,304 New
QBFM
11
QS Batterymarch Financial Management
New York
$3.89M +$3.73M +783,317 New
AQR Capital Management
12
AQR Capital Management
Connecticut
$3.85M +$3.69M +775,400 New
Acadian Asset Management
13
Acadian Asset Management
Massachusetts
$2.95M +$2.83M +594,163 New
TC
14
TFS Capital
Pennsylvania
$2.83M +$2.71M +570,502 New
JP Morgan Chase
15
JP Morgan Chase
New York
$2.52M +$2.42M +508,799 New
Bank of New York Mellon
16
Bank of New York Mellon
New York
$1.78M +$1.71M +358,355 New
TCIM
17
TIAA CREF Investment Management
New York
$1.72M +$1.65M +347,259 New
AL
18
AJO LP
Pennsylvania
$1.58M +$1.51M +317,700 New
BA
19
BlackRock Advisors
Delaware
$1.36M +$1.31M +274,687 New
GC
20
Globeflex Capital
California
$1.32M +$1.27M +266,678 New
Geode Capital Management
21
Geode Capital Management
Massachusetts
$1.16M +$1.11M +233,248 New
Wellington Management Group
22
Wellington Management Group
Massachusetts
$1.04M +$1M +210,238 New
Morgan Stanley
23
Morgan Stanley
New York
$1.03M +$991K +208,192 New
PP
24
PDT Partners
New York
$1.01M +$974K +204,700 New
Millennium Management
25
Millennium Management
New York
$978K +$938K +197,192 New
1
2 3 4 5

SCLN Hedge Fund Activity: Q2 2013 in Review

104 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Sciclone Pharmaceuticals Inc (SCLN) for Q2 2013, worth a combined $147M.

Buyers outnumbered sellers: 104 funds opened new SCLN positions and 0 closed out — a net gain of 104 holders — while 0 added to existing stakes and 0 trimmed.

  • 104 institutional investors held Sciclone Pharmaceuticals Inc (SCLN) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $147M of Sciclone Pharmaceuticals Inc stock for Q2 2013.
  • 104 funds opened new Sciclone Pharmaceuticals Inc positions in Q2 2013 and 0 closed out, a net change of +104 holders.

Based on aggregated 13F filings for Q2 2013.